 BURLINGTON, Mass., May 25, 2021 GLOBE NEWSWIRE -- LeMaitre Nasdaq:LMAT, a provider of vascular devices, implants and services, today announced that it received CE marks under the European Medical Devices Directive 9342EC as amended by 200747EC for the following five products. Marks for the five products had previously lapsed due to a change in notified bodies. 